Analysed ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) News Sources
How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%
09-07-2026
yahoo.com
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
26-07-2026
yahoo.com
Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know
27-07-2026
yahoo.com
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
02-08-2026
yahoo.com
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05-08-2026
yahoo.com
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05-08-2026
yahoo.com
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
13-08-2026
yahoo.com
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
19-08-2026
yahoo.com
What is the current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is $16.9.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is $0.11.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is 0.6552%.
What is the most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is 50 out of 100.
What is the most recent average sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is .
SEC-8K** Filing Available For ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.